These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
556 related items for PubMed ID: 26477638
1. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in the MPTP-induced mouse model of Parkinson's disease: Involvement of reactive oxygen species-mediated JNK, P38 and mitochondrial pathways. He H, Wang S, Tian J, Chen L, Zhang W, Zhao J, Tang H, Zhang X, Chen J. Eur J Pharmacol; 2015 Nov 15; 767():175-82. PubMed ID: 26477638 [Abstract] [Full Text] [Related]
4. Tetrahydroxystilbene glucoside attenuates MPP+-induced apoptosis in PC12 cells by inhibiting ROS generation and modulating JNK activation. Li X, Li Y, Chen J, Sun J, Li X, Sun X, Kang X. Neurosci Lett; 2010 Oct 08; 483(1):1-5. PubMed ID: 20643188 [Abstract] [Full Text] [Related]
8. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid. Karunakaran S, Diwakar L, Saeed U, Agarwal V, Ramakrishnan S, Iyengar S, Ravindranath V. FASEB J; 2007 Jul 08; 21(9):2226-36. PubMed ID: 17369508 [Abstract] [Full Text] [Related]
9. Tetrahydroxystilbene glucoside protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. Sun FL, Zhang L, Zhang RY, Li L. Eur J Pharmacol; 2011 Jun 25; 660(2-3):283-90. PubMed ID: 21497157 [Abstract] [Full Text] [Related]
10. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease. Castro-Caldas M, Carvalho AN, Rodrigues E, Henderson CJ, Wolf CR, Rodrigues CM, Gama MJ. Mol Neurobiol; 2012 Oct 25; 46(2):475-86. PubMed ID: 22773138 [Abstract] [Full Text] [Related]
12. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. Shin JY, Park HJ, Ahn YH, Lee PH. J Neurochem; 2009 Nov 25; 111(4):1042-50. PubMed ID: 19765187 [Abstract] [Full Text] [Related]
14. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease. Zheng M, Liu C, Fan Y, Yan P, Shi D, Zhang Y. Neuropharmacology; 2017 Apr 25; 116():412-420. PubMed ID: 28093210 [Abstract] [Full Text] [Related]
15. Neuroprotective effects of 2,3,5,4'-tetrahydoxystilbene-2-O-β-D-glucoside from Polygonum multiflorum against glutamate-induced oxidative toxicity in HT22 cells. Lee SY, Ahn SM, Wang Z, Choi YW, Shin HK, Choi BT. J Ethnopharmacol; 2017 Jan 04; 195():64-70. PubMed ID: 27939422 [Abstract] [Full Text] [Related]
16. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta. Boyd JD, Jang H, Shepherd KR, Faherty C, Slack S, Jiao Y, Smeyne RJ. Brain Res; 2007 Oct 17; 1175():107-16. PubMed ID: 17884023 [Abstract] [Full Text] [Related]
17. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice. Guo C, Hao LJ, Yang ZH, Chai R, Zhang S, Gu Y, Gao HL, Zhong ML, Wang T, Li JY, Wang ZY. Exp Neurol; 2016 Jun 17; 280():13-23. PubMed ID: 26996132 [Abstract] [Full Text] [Related]
20. JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease. Huang Q, Du X, He X, Yu Q, Hu K, Breitwieser W, Shen Q, Ma S, Li M. Exp Neurol; 2016 Mar 17; 277():296-304. PubMed ID: 26515688 [Abstract] [Full Text] [Related] Page: [Next] [New Search]